Minna Sivonen

My research focuses on developing next-generation cancer immunotherapies, with a particular emphasis on biomimetic cancer nanovaccines. We utilize virus-like mesoporous silica nanoparticles (VLNPs) designed to mimic viral structures and enhance immune system activation. By optimizing the surface features of these nanoparticles and incorporating cancer cell membranes, we aim to stimulate the immune response against cancer, more specifically activation of NK and T cells.